Iranian Journal of Medical Sciences

Medicinal Herbs for the Treatment of Androgenic Alopecia: A Scoping Review of Clinical Trials

Document Type : Review Article

Authors

1 Molecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

2 Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

3 Department of Medical Journalism, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran

4 Student Research Committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

5 Department of Dermatology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

10.30476/ijms.2026.111000.4693
Abstract
Background: Androgenetic alopecia (AGA), encompassing both male and female pattern hair loss, is a prevalent condition. Given the considerable evidence supporting the efficacy of medicinal plants and traditional medicine in managing AGA, this study aimed to review and summarize the findings of clinical trials conducted in this field.
Methods: A comprehensive literature search was conducted in the Scopus, PubMed, and Web of Science databases to identify clinical trials published between January 2000 and December 2025. Search terms included “alopecia”, “complementary therapies”, “medicinal plants”, and “clinical trials”, along with their corresponding Medical Subject Headings (MeSH). Case reports, reviews, animal studies, and non-English publications were excluded. Data on general study characteristics, including authors, year of publication, and geographic location, were extracted. Detailed data regarding sample size, study design and group allocation, participant demographics, specific interventions, primary outcome measures, and reported outcomes were systematically documented.
Results: A total of 27 eligible trials were identified from an initial pool of 814 articles. The majority of these trials reported significant improvements in hair growth parameters (e.g., hair count, thickness) and positive safety profiles. This scoping review indicated that various herbal-based remedies, including specific fruits and flowers, were effective in treating AGA. Key effective botanical agents included extracts from Malus domestica, Serenoa repens, and Trifolium pretense. Notably, most studies originated from South Korea, indicating the need for caution regarding the generalizability of these findings.
Conclusion: The findings of the present study suggested that medicinal herbs, used either individually or in combination, had therapeutic potential for the management of AGA.

Highlights

Mohammad Mahdi Parvizi (Google Scholar) 
Maryam Sadat Sadati (Google Scholar)

 

Keywords


1.     McDonough PH, Schwartz RA. Adolescent androgenic alopecia. Cutis. 2011;88:165-8. PubMed PMID: 22106721.
2.     Suchonwanit P, Iamsumang W, Leerunyakul K. Topical finasteride for the treatment of male androgenetic alopecia and female pattern hair loss: a review of the current literature. J Dermatolog Treat. 2022;33:643-8. doi: 10.1080/09546634.2020.1782324. PubMed PMID: 32538225.
3.     Williams R, Pawlus AD, Thornton MJ. Getting under the skin of hair aging: the impact of the hair follicle environment. Exp Dermatol. 2020;29:588-97. doi: 10.1111/exd.14109. PubMed PMID: 32358903.
4.     Olsen EA. Female pattern hair loss. J Am Acad Dermatol. 2001;45:S70-80. doi: 10.1067/mjd.2001.117426. PubMed PMID: 11511856.
5.     Ramos PM, Miot HA. Female Pattern Hair Loss: a clinical and pathophysiological review. An Bras Dermatol. 2015;90:529-43. doi: 10.1590/abd1806-4841.20153370. PubMed PMID: 26375223; PubMed Central PMCID: PMC4560543.
6.     Birch MP, Messenger JF, Messenger AG. Hair density, hair diameter and the prevalence of female pattern hair loss. Br J Dermatol. 2001;144:297-304. doi: 10.1046/j.1365-2133.2001.04018.x. PubMed PMID: 11251562.
7.     Gan DC, Sinclair RD. Prevalence of male and female pattern hair loss in Maryborough. J Investig Dermatol Symp Proc. 2005;10:184-9. doi: 10.1111/j.1087-0024.2005.10102.x. PubMed PMID: 16382660.
8.     Vano-Galvan S, Saceda-Corralo D, Blume-Peytavi U, Cucchia J, Dlova NC, Gavazzoni Dias MFR, et al. Frequency of the Types of Alopecia at Twenty-Two Specialist Hair Clinics: A Multicenter Study. Skin Appendage Disord. 2019;5:309-15. doi: 10.1159/000496708. PubMed PMID: 31559256; PubMed Central PMCID: PMC6751437.
9.     Russo PM, Fino E, Mancini C, Mazzetti M, Starace M, Piraccini BM. HrQoL in hair loss-affected patients with alopecia areata, androgenetic alopecia and telogen effluvium: the role of personality traits and psychosocial anxiety. J Eur Acad Dermatol Venereol. 2019;33:608-11. doi: 10.1111/jdv.15327. PubMed PMID: 30394586.
10.  Lucky AW, Piacquadio DJ, Ditre CM, Dunlap F, Kantor I, Pandya AG, et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol. 2004;50:541-53. doi: 10.1016/j.jaad.2003.06.014. PubMed PMID: 15034503.
11.  Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002;47:377-85. doi: 10.1067/mjd.2002.124088. PubMed PMID: 12196747.
12.  Blume-Peytavi U, Shapiro J, Messenger AG, Hordinsky MK, Zhang P, Quiza C, et al. Efficacy and Safety of Once-Daily Minoxidil Foam 5% Versus Twice-Daily Minoxidil Solution 2% in Female Pattern Hair Loss: A Phase III, Randomized, Investigator-Blinded Study. J Drugs Dermatol. 2016;15:883-9. PubMed PMID: 27391640.
13.  Nestor MS, Ablon G, Gade A, Han H, Fischer DL. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021;20:3759-81. doi: 10.1111/jocd.14537. PubMed PMID: 34741573; PubMed Central PMCID: PMC9298335.
14.  Price VH, Roberts JL, Hordinsky M, Olsen EA, Savin R, Bergfeld W, et al. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol. 2000;43:768-76. doi: 10.1067/mjd.2000.107953. PubMed PMID: 11050579.
15.  Azarchi S, Bienenfeld A, Lo Sicco K, Marchbein S, Shapiro J, Nagler AR. Androgens in women: Hormone-modulating therapies for skin disease. J Am Acad Dermatol. 2019;80:1509-21. doi: 10.1016/j.jaad.2018.08.061. PubMed PMID: 30312645.
16.  Arif T, Dorjay K, Adil M, Sami M. Dutasteride in Androgenetic Alopecia: An Update. Curr Clin Pharmacol. 2017;12:31-5. doi: 10.2174/1574884712666170310111125. PubMed PMID: 28294070.
17.  Olsen EA, Hordinsky M, Whiting D, Stough D, Hobbs S, Ellis ML, et al. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol. 2006;55:1014-23. doi: 10.1016/j.jaad.2006.05.007. PubMed PMID: 17110217.
18.  Sinclair R, Wewerinke M, Jolley D. Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol. 2005;152:466-73. doi: 10.1111/j.1365-2133.2005.06218.x. PubMed PMID: 15787815.
19.  Famenini S, Slaught C, Duan L, Goh C. Demographics of women with female pattern hair loss and the effectiveness of spironolactone therapy. J Am Acad Dermatol. 2015;73:705-6. doi: 10.1016/j.jaad.2015.06.063. PubMed PMID: 26369846; PubMed Central PMCID: PMC4573453.
20.  Anitua E, Sanchez M, Nurden AT, Nurden P, Orive G, Andia I. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol. 2006;24:227-34. doi: 10.1016/j.tibtech.2006.02.010. PubMed PMID: 16540193.
21.  Avram MR, Rogers NE. The use of low-level light for hair growth: part I. J Cosmet Laser Ther. 2009;11:110-7. doi: 10.1080/14764170902842531. PubMed PMID: 19466643.
22.  Galadari H, Shivakumar S, Lotti T, Wollina U, Goren A, Rokni GR, et al. Low-level laser therapy and narrative review of other treatment modalities in androgenetic alopecia. Lasers Med Sci. 2020;35:1239-44. doi: 10.1007/s10103-020-02994-4. PubMed PMID: 32162134.
23.  Fertig RM, Gamret AC, Cervantes J, Tosti A. Microneedling for the treatment of hair loss? J Eur Acad Dermatol Venereol. 2018;32:564-9. doi: 10.1111/jdv.14722. PubMed PMID: 29194786.
24.  Fabbrocini G, Cantelli M, Masara A, Annunziata MC, Marasca C, Cacciapuoti S. Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review. Int J Womens Dermatol. 2018;4:203-11. doi: 10.1016/j.ijwd.2018.05.001. PubMed PMID: 30627618; PubMed Central PMCID: PMC6322157.
25.  Zhang J, Onakpoya IJ, Posadzki P, Eddouks M. The safety of herbal medicine: from prejudice to evidence. Evid Based Complement Alternat Med. 2015;2015:316706. doi: 10.1155/2015/316706. PubMed PMID: 25838831; PubMed Central PMCID: PMC4370194.
26.  Parvizi MM, Fatehi N, Jaladat AM, Gholampour Z, Shahriarirad R, Erfani A. Epidemiological factors in patients with dermatologic conditions referring to the clinic of traditional Persian Medicine: A cross-sectional study. Int J Clin Pract. 2021;75:e14788. doi: 10.1111/ijcp.14788. PubMed PMID: 34480839.
27.  Pasalar M, Tabatabaei F, Bradley R, Tajadini H, Kamali M, Hasheminasab FS, et al. Mechanistic support of traditional Persian medicine for the treatment of acne vulgaris: A scoping review. J Cosmet Dermatol. 2022;21:2338-48. doi: 10.1111/jocd.14464. PubMed PMID: 34564932.
28.  Evron E, Juhasz M, Babadjouni A, Mesinkovska NA. Natural Hair Supplement: Friend or Foe? Saw Palmetto, a Systematic Review in Alopecia. Skin Appendage Disord. 2020;6:329-37. doi: 10.1159/000509905. PubMed PMID: 33313047; PubMed Central PMCID: PMC7706486.
29.  Choi BY. Hair-Growth Potential of Ginseng and Its Major Metabolites: A Review on Its Molecular Mechanisms. Int J Mol Sci. 2018;19. doi: 10.3390/ijms19092703. PubMed PMID: 30208587; PubMed Central PMCID: PMC6163201.
30.  Zgonc Skulj A, Poljsak N, Kocevar Glavac N, Kreft S. Herbal preparations for the treatment of hair loss. Arch Dermatol Res. 2020;312:395-406. doi: 10.1007/s00403-019-02003-x. PubMed PMID: 31680216.
31.  Lourith N, Kanlayavattanakul M. Hair loss and herbs for treatment. J Cosmet Dermatol. 2013;12:210-22. doi: 10.1111/jocd.12051. PubMed PMID: 23992163.
32.  Akhbari M, Firooz A, Rahimi R, Shirzad M, Esmaealzadeh N, Shirbeigi L. The effect of an oral product containing Amla fruit (Phyllanthus emblica L.) on female androgenetic alopecia: A randomized controlled trial. J Ethnopharmacol. 2024;318:116958. doi: 10.1016/j.jep.2023.116958. PubMed PMID: 37487962.
33.  Kumari I, Kaurav H, Chaudhary G. Eclipta alba (bhringraj): A promising hepatoprotective and hair growth stimulating herb. Asian J Pharm Clin Res. 2021;14:16-23. doi: 10.22159/ajpcr.2021v14i7.41569.
34.  Bouissane L, Elfardi Y, Khatib S, Fatimi A, Pereira C, Cruz-Martins N. Medicinal plants and their derivatives for skin and hair: a Mediterranean perspective of women care. Arch Dermatol Res. 2025;317:710. doi: 10.1007/s00403-025-04202-1. PubMed PMID: 40221958; PubMed Central PMCID: PMC11994543.
35.  Kamimura A, Takahashi T, Watanabe Y. Investigation of topical application of procyanidin B-2 from apple to identify its potential use as a hair growing agent. Phytomedicine. 2000;7:529-36. doi: 10.1016/S0944-7113(00)80040-9. PubMed PMID: 11194183.
36.  Prager N, Bickett K, French N, Marcovici G. A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia. J Altern Complement Med. 2002;8:143-52. doi: 10.1089/acm.2002.8.143. PubMed PMID: 12006122.
37.  Moers-Carpi M. Nutritive beeinflussung des haarwachstums. Aktuelle Dermatologie. 2011;37:171-5. doi: 10.1055/s-0030-1256369.
38.  Pumthong G, Asawanonda P, Varothai S, Jariyasethavong V, Triwongwaranat D, Suthipinittharm P, et al. Curcuma aeruginosa, a novel botanically derived 5alpha-reductase inhibitor in the treatment of male-pattern baldness: a multicenter, randomized, double-blind, placebo-controlled study. J Dermatolog Treat. 2012;23:385-92. doi: 10.3109/09546634.2011.568470. PubMed PMID: 21756154.
39.  Rossi A, Mari E, Scarno M, Garelli V, Maxia C, Scali E, et al. Comparitive effectiveness of finasteride vs Serenoa repens in male androgenetic alopecia: a two-year study. Int J Immunopathol Pharmacol. 2012;25:1167-73. doi: 10.1177/039463201202500435. PubMed PMID: 23298508.
40.  Loing E, Lachance R, Ollier V, Hocquaux M. A new strategy to modulate alopecia using a combination of two specific and unique ingredients. J Cosmet Sci. 2013;64:45-58. PubMed PMID: 23449130.
41.  Choi JS, Park JB, Moon WS, Moon JN, Son SW, Kim MR. Safety and Efficacy of Rice Bran Supercritical CO2 Extract for Hair Growth in Androgenic Alopecia: A 16-Week Double-Blind Randomized Controlled Trial. Biol Pharm Bull. 2015;38:1856-63. doi: 10.1248/bpb.b15-00387. PubMed PMID: 26632177.
42.  Panahi Y, Taghizadeh M, Marzony ET, Sahebkar A. Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial. Skinmed. 2015;13:15-21. PubMed PMID: 25842469.
43.  Lee CY, Wei CC, Yu MC, Lin CC, Sheu SJ, Yang JH, et al. Hair growth effect of traditional Chinese medicine BeauTop on androgenetic alopecia patients: A randomized double-blind placebo-controlled clinical trial. Exp Ther Med. 2017;13:194-202. doi: 10.3892/etm.2016.3935. PubMed PMID: 28123489; PubMed Central PMCID: PMC5245083.
44.  Pekmezci E, Dundar C, Turkoglu M. A proprietary herbal extract against hair loss in androgenetic alopecia and telogen effluvium: a placebo-controlled, single-blind, clinical-instrumental study. Acta Dermatovenerol Alp Pannonica Adriat. 2018;27:51-7. PubMed PMID: 29945259.
45.  Takahashi T, Ishino A, Arai T, Hamada C, Nakazawa Y, Iwabuchi T, et al. Improvement of androgenetic alopecia with topical Sophora flavescens Aiton extract, and identification of the two active compounds in the extract that stimulate proliferation of human hair keratinocytes. Clin Exp Dermatol. 2016;41:302-7. doi: 10.1111/ced.12753. PubMed PMID: 26453439.
46.  Wessagowit V, Tangjaturonrusamee C, Kootiratrakarn T, Bunnag T, Pimonrat T, Muangdang N, et al. Treatment of male androgenetic alopecia with topical products containing Serenoa repens extract. Australas J Dermatol. 2016;57:e76-82. doi: 10.1111/ajd.12352. PubMed PMID: 26010505.
47.  Srivilai J, Phimnuan P, Jaisabai J, Luangtoomma N, Waranuch N, Khorana N, et al. Curcuma aeruginosa Roxb. essential oil slows hair-growth and lightens skin in axillae; a randomised, double blinded trial. Phytomedicine. 2017;25:29-38. doi: 10.1016/j.phymed.2016.12.007. PubMed PMID: 28190468.
48.  Ablon G, Kogan S. A Six-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of a Nutraceutical Supplement for Promoting Hair Growth in Women With Self-Perceived Thinning Hair. J Drugs Dermatol. 2018;17:558-65. PubMed PMID: 29742189.
49.  Srivilai J, Nontakhot K, Nutuan T, Waranuch N, Khorana N, Wisuthiprot W, et al. Sesquiterpene-Enriched Extract of Curcuma aeruginosa Roxb. Retards Axillary Hair Growth: A Randomised, Placebo-Controlled, Double-Blind Study. Skin Pharmacol Physiol. 2018;31:99-106. doi: 10.1159/000486136. PubMed PMID: 29428960.
50.  Choi HC, Nam GW, Jeong NH, Choi BY. Hair growth promotion by extracts of Inula Helenium and Caesalpinia Sappan Bark in patients with androgenetic alopecia: A pre-clinical study using phototrichogram analysis. Cosmetics. 2019;6:66. doi: 10.3390/cosmetics6040066.
51.  Kim BH, Lee W-Y, Trinh TA, Pyo JS, Lee S, Kim C-E, et al. Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima. Processes. 2020;8:767. doi: 10.3390/pr8070767.
52.  Masoud F, Alamdari HA, Asnaashari S, Shokri J, Javadzadeh Y. Efficacy and safety of a novel herbal solution for the treatment of androgenetic alopecia and comparison with 5% minoxidil: A double-blind, randomized controlled trial study. Dermatol Ther. 2020;33:e14467. doi: 10.1111/dth.14467. PubMed PMID: 33112463.
53.   Ibrahim IM, Hasan MS, Elsabaa KI, Elsaie ML. Pumpkin seed oil vs. minoxidil 5% topical foam for the treatment of female pattern hair loss: A randomized comparative trial. J Cosmet Dermatol. 2021;20:2867-73. doi: 10.1111/jocd.13976. PubMed PMID: 33544448.
54.  Lee SB, Hwang HW, Heo JH, Lee SH, Shin HT, Byun JW, et al. The efficacy and safety of the topical application of poly-gamma glutamic acid hydrogel nanoparticle-based fermented extract of a medicinal plant solution for androgenetic alopecia: a randomized double-blinded placebo-controlled clinical trial. Korean J Dermatol. 2021;59(2):81-7.
55.  Woo YM, Seo JY, Kim S-y, Cha JH, Cho HD, Cha YK, et al. Hair Growth Effect of TS-SCLF from Schisandra chinensis Extract Fermented with Lactobacillus plantarum. Microbiology and Biotechnology Letters. 2022;50:533-47. doi: 10.48022/mbl.2206.06011.
56.  Cai C, Zeng B, Lin L, Zheng M, Burki C, Grether-Beck S, et al. An oral French maritime pine bark extract improves hair density in menopausal women: A randomized, placebo-controlled, double blind intervention study. Health Sci Rep. 2023;6:e1045. doi: 10.1002/hsr2.1045. PubMed PMID: 36620515; PubMed Central PMCID: PMC9817492.
57.  De Biasio F, Ielpo A, Santarsiere L, Ivaldi L, Salamone R, Gorgoglione D. A randomized double-blind placebo-controlled clinical trial to evaluate the effect of an Annurca apple supplement formula in androgenic alopecia. Journal of Applied Cosmetology. 2023;41:28/46-28/46. doi: 10.56609/jac.v41i2.276.
58.  Mayer W, Weibel M, De Luca C, Ibragimova G, Trakhtman I, Kharaeva Z, et al. Biomolecules of Fermented Tropical Fruits and Fermenting Microbes as Regulators of Human Hair Loss, Hair Quality, and Scalp Microbiota. Biomolecules. 2023;13. doi: 10.3390/biom13040699. PubMed PMID: 37189446; PubMed Central PMCID: PMC10136211.
59.  Tanuphol N, Waranuch N, Wisuitiprot V, Wisuitiprot W, Insumrong K, Temkitthawon P, et al. Effectiveness and Safety of Hair Growth Formulation Containing Tectona grandis L.f (Teak) Leaf Extract: A Randomized, Double-Blind, Placebo-Controlled Study on Males with Androgenic Alopecia. J Evid Based Integr Med. 2024;29:2515690X241291141. doi: 10.1177/2515690X241291141. PubMed PMID: 39474646; PubMed Central PMCID: PMC11612263.
60.  Amini F, Teh JJ, Tan CK, Tan ESS, Ng ESC. A Pilot Randomized Controlled Trial (RCT) Evaluating the Efficacy of an Exosome-Containing Plant Extract Formulation for Treating Male Alopecia. Life (Basel). 2025;15. doi: 10.3390/life15030500. PubMed PMID: 40141845; PubMed Central PMCID: PMC11943915.
61.  Tenore GC, Caruso D, Buonomo G, D’Avino M, Santamaria R, Irace C, et al. Annurca Apple Nutraceutical Formulation Enhances Keratin Expression in a Human Model of Skin and Promotes Hair Growth and Tropism in a Randomized Clinical Trial. J Med Food. 2018;21:90-103. doi: 10.1089/jmf.2017.0016. PubMed PMID: 28956697; PubMed Central PMCID: PMC5775114.
62.  Ahmad B, Hafeez N, Rauf A, Bashir S, Linfang H, Rehman M-u, et al. Phyllanthus emblica: A comprehensive review of its therapeutic benefits. South African Journal of Botany. 2021;138:278-310. doi: 10.1016/j.sajb.2020.12.028.
63.  Kaurinovic B, Popovic M, Vlaisavljevic S, Schwartsova H, Vojinovic-Miloradov M. Antioxidant profile of Trifolium pratense L. Molecules. 2012;17:11156-72. doi: 10.3390/molecules170911156. PubMed PMID: 22990457; PubMed Central PMCID: PMC6268542.
64.  Albayrak S, Cinar A, Paksoy M, Aksoy A. An investigation on antioxidant and antimicrobial activities of four Inula helenium L. taxa. Iranian Journal of Science and Technology. 2015;39:473-83.
65.  Geavlete P, Multescu R, Geavlete B. Serenoa repens extract in the treatment of benign prostatic hyperplasia. Ther Adv Urol. 2011;3:193-8. doi: 10.1177/1756287211418725. PubMed PMID: 21969849; PubMed Central PMCID: PMC3175703.
66.  Bin-Hafeez B, Haque R, Parvez S, Pandey S, Sayeed I, Raisuddin S. Immunomodulatory effects of fenugreek (Trigonella foenum graecum L.) extract in mice. Int Immunopharmacol. 2003;3:257-65. doi: 10.1016/S1567-5769(02)00292-8. PubMed PMID: 12586606.
67.  Bukhari SB, Bhanger MI, Memon S. Antioxidative activity of extracts from fenugreek. Pak J Anal Environ Chem Vol. 2008;9:78-83.
68.  Xue WL, Li XS, Zhang J, Liu YH, Wang ZL, Zhang RJ. Effect of Trigonella foenum-graecum (fenugreek) extract on blood glucose, blood lipid and hemorheological properties in streptozotocin-induced diabetic rats. Asia Pac J Clin Nutr. 2007;16 Suppl 1:422-6. PubMed PMID: 17392143.
69.  Amiri Ardekani E, Parvizi MM, Zare R, Mosaffa Jahromi M, Rampp T, Pasalar M. Exploring the Adverse Effects of Fenugreek in Humans: A Scoping Review. Iran J Med Sci. 2026;51:4-18. doi: 10.30476/ijms.2025.106073.4017. PubMed PMID: 41625343; PubMed Central PMCID: PMC12858439.
70.  Salido S, Altarejos J, Nogueras M, Saánchez A, Luque P. Chemical composition and seasonal variations of rosemary oil from southern Spain. Journal of Essential Oil Research. 2003;15:10-4. doi: 10.1080/10412905.2003.9712248.
71.  Sadati MS, Alesana F, Hekmat M, Parvizi MM. Efficacy of Topical Rosemary Extract Lotion versus Topical 2% Ketoconazole Lotion in the Treatment of Seborrheic Dermatitis: A Double-Blind Randomized Controlled Clinical Trial. Dermatol Pract Concept. 2024;14. doi: 10.5826/dpc.1404a242. PubMed PMID: 39652968; PubMed Central PMCID: PMC11619942.
72.  Sohail M, Rakha A, Butt MS, Iqbal MJ, Rashid S. Rice bran nutraceutics: A comprehensive review. Crit Rev Food Sci Nutr. 2017;57:3771-80. doi: 10.1080/10408398.2016.1164120. PubMed PMID: 27015585.
73.  Kuk M, Dowd M. Supercritical CO2 extraction of rice bran. Journal of the American Oil Chemists’ Society. 1998;75:623-8. doi: 10.1007/s11746-998-0075-y.
74.  Lueangarun S, Panchaprateep R. An Herbal Extract Combination (Biochanin A, Acetyl tetrapeptide-3, and Ginseng Extracts) versus 3% Minoxidil Solution for the Treatment of Androgenetic Alopecia: A 24-week, Prospective, Randomized, Triple-blind, Controlled Trial. J Clin Aesthet Dermatol. 2020;13:32-7. PubMed PMID: 33584955; PubMed Central PMCID: PMC7840088.
75.  Vardhani AK. Caesalpinia sappan L: REVIEW ARTICLE. Proc Int Conf Appl Sci Heal. 2019;300-5.
76.   Nirmal NP, Rajput MS, Prasad RG, Ahmad M. Brazilin from Caesalpinia sappan heartwood and its pharmacological activities: A review. Asian Pac J Trop Med. 2015;8:421-30. doi: 10.1016/j.apjtm.2015.05.014. PubMed PMID: 26194825.

Articles InPress, Corrected Proof
Available Online from 21 November 2026


  • Received 14 March 2026
  • Revised 09 June 2026
  • Accepted 17 July 2026